An increase in estimated pulse wave velocity was positively associated with all-cause mortality (HR 1.180) in patients with coronary artery disease, particularly when exceeding 11.15 m/s.
Cohort (n=402)
Does higher estimated pulse wave velocity (ePWV) predict increased all-cause mortality in patients with coronary artery disease?
In patients with coronary artery disease, an estimated pulse wave velocity (ePWV) greater than 11.15 m/s is significantly associated with an increased risk of all-cause mortality.
Effect estimate: HR 1.180 (95% CI 1.056-1.320)
p-value: p=0.0036
BACKGROUND: Arterial stiffness has been shown to be an independent risk factor for adverse events and all-cause mortality in patients. Although PWV is the gold standard for pulse wave velocity, its application in clinical practice is limited by the high cost and complexity. ePwv is a new, simple, non-invasive indicator of arterial stiffness. The aim of this study was to assess the relationship between ePwv and all-cause mortality in patients with coronary artery disease. METHODS: This is a cohort study, selected from NHANES 2005 to 2008, 402 patients with coronary artery disease were included. The ePWV was divided into two groups and KM survival curves were used to calculate cumulative mortality in patients with coronary artery disease. Restricted cubic spline were used to represent the relationship between ePWV and all-cause mortality in patients with coronary artery disease. Cox regression was used to diagnose the relationship between ePwv and all-cause mortality. RESULTS: The mean age of the study subjects was 68.5 ± 11.8 years, of which 282 (70.1%) were men and 120 (29.9%) were women. During 180 months of follow-up, 160 all-cause mortality occurred. KM survival curves indicated that all-cause mortality increased with increasing ePWV. The relationship between ePWV and all-cause mortality in patients with coronary artery disease was verified by cox models. Patients in higher ePWV tertile tended to have higher all-cause mortality. After complete multivariate adjustment, an increase in ePWV was positively associated with all-cause mortality (HR = 1.180, 95% confidence interval (CI): 1.056-1.320). The multivariate-adjusted HR and 95% CI for the highest ePWV tertile was 1.582 (95% CI: 0.968-2.587) compared to the lowest tertile. In addition, the association between ePWV and mortality was visualized employing restricted spline curves, in which we found curves indicating a possible threshold for the effect of ePWV on all-cause mortality, with HR less than 1 when ePWV was less than 11.15 m/s; thereafter, there was a tendency for HR to increase with enhanced ePWV. Subgroup analysis showed that the correlation between ePWV and mortality persisted in population subgroups. CONCLUSION: Our findings suggest that higher ePWV is associated with increased all-cause mortality in patients with coronary artery disease, particularly when ePWV exceeds 11.15 m/s.
Chen et al. (2023) conducted a cohort in Coronary artery disease (n=402). Higher estimated pulse wave velocity (ePWV) vs. Lower estimated pulse wave velocity was evaluated on All-cause mortality (HR 1.180, 95% CI 1.056-1.320, p=0.0036). An increase in estimated pulse wave velocity was positively associated with all-cause mortality (HR 1.180) in patients with coronary artery disease, particularly when exceeding 11.15 m/s.